Madeleine McDowell, MD, FAAP

Madeleine McDowell, MD, FAAP

Madeleine McDowell, MD, FAAP Principal and Medical Director

Madeleine provides clinical insight and expertise across Sg2’s intelligence research. She also directs components of Sg2’s pediatric and adult general medicine intelligence, including the Sg2 Impact of Change demand forecast.


"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."

As of February 11, 2016, Vizient, Inc. has completed its purchase of MedAssets Sg2 and spend and clinical resource management segments from Pamplona Capital Management, LLC. MedAssets revenue cycle business will continue to operate as a wholly-owned subsidiary of Pamplona Capital Management LLP.

Follow Sg2 on Twitter Connect with Sg2 on LinkedIn Watch Sg2 on YouTube